Jan Lillienau
- Co-authors
- Alan F. HofmannHuong‐Thu Ton‐NuKim E. BarrettClaudio D. SchteingartC D SchteingartErik HertervigDiane L. CrombieRong Duan
- Topics
- Drug Transport and Resistance Mechanisms (14 papers)Pediatric Hepatobiliary Diseases and Treatments (6 papers)Gastroesophageal reflux and treatments (3 papers)
- Cited by
- GastroenterologyOncologyHepatology
- Partner nations
- SwedenUnited StatesRussia
In The Last Decade
Jan Lillienau
21 papers receiving 566 citations
Peers
Comparison fields: 5 of 66
- Oncology 282
- Surgery 247
- Molecular Biology 132
- Pediatrics, Perinatology and Child Health 92
- Epidemiology 90
Countries citing papers authored by Jan Lillienau
This map shows the geographic impact of Jan Lillienau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Lillienau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Lillienau more than expected).
Fields of papers citing papers by Jan Lillienau
This network shows the impact of papers produced by Jan Lillienau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Lillienau. The network helps show where Jan Lillienau may publish in the future.
Co-authorship network of co-authors of Jan Lillienau
This figure shows the co-authorship network connecting the top 25 collaborators of Jan Lillienau. A scholar is included among the top collaborators of Jan Lillienau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Lillienau. Jan Lillienau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 26 | |
| 4 | 11 | |
| 5 | 13 | |
| 6 | 86 | |
| 7 | 63 | |
| 8 | 35 | |
| 9 | 45 | |
| 10 | 12 | |
| 11 | 20 | |
| 12 | 11 | |
| 13 | 6 | |
| 14 | 23 | |
| 15 | 50 | |
| 16 | 137 | |
| 17 | 2 | |
| 18 | 6 | |
| 19 | 6 | |
| 20 | 19 |
About Jan Lillienau
Jan Lillienau is a scholar working on Gastroenterology, Oncology and Clinical Biochemistry, having authored 22 papers that have together received 582 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (14 papers), Pediatric Hepatobiliary Diseases and Treatments (6 papers) and Gastroesophageal reflux and treatments (3 papers). The work is most often cited by research in Gastroenterology (66 citations), Oncology (282 citations) and Hepatology (75 citations). Jan Lillienau has collaborated with scholars based in Sweden, United States and Russia. Frequent co-authors include Alan F. Hofmann, Huong‐Thu Ton‐Nu, Kim E. Barrett, Claudio D. Schteingart, C D Schteingart, Erik Hertervig, Diane L. Crombie, Rong Duan, Lee R. Hagey and Aijaz Farooqi. Their work appears in journals such as Journal of Clinical Investigation, Gastroenterology and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.